Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 June 2018

Lithuanian is available via eTranslation, the European Commission's machine translation service.

Translate to Lithuanian | Important information about machine translation

Date

Pirmadienis, 11 Birželis 2018, All day

Vieta

European Medicines Agency, Amsterdam, the Netherlands

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Documents

български (BG) (254.09 KB - PDF)

Rodyti

español (ES) (223.77 KB - PDF)

Rodyti

čeština (CS) (245.83 KB - PDF)

Rodyti

dansk (DA) (220.97 KB - PDF)

Rodyti

Deutsch (DE) (225.02 KB - PDF)

Rodyti

eesti (ET) (219.98 KB - PDF)

Rodyti

ελληνικά (EL) (260.1 KB - PDF)

Rodyti

français (FR) (225.33 KB - PDF)

Rodyti

hrvatski (HR) (239.57 KB - PDF)

Rodyti

italiano (IT) (222.54 KB - PDF)

Rodyti

latviešu (LV) (252.56 KB - PDF)

Rodyti

lietuvių (LT) (244.9 KB - PDF)

Rodyti

magyar (HU) (246.89 KB - PDF)

Rodyti

Malti (MT) (250.25 KB - PDF)

Rodyti

Nederlands (NL) (223.78 KB - PDF)

Rodyti

polski (PL) (249.58 KB - PDF)

Rodyti

português (PT) (224.7 KB - PDF)

Rodyti

română (RO) (248.09 KB - PDF)

Rodyti

slovenčina (SK) (244.56 KB - PDF)

Rodyti

slovenščina (SL) (241.23 KB - PDF)

Rodyti

suomi (FI) (222.25 KB - PDF)

Rodyti

svenska (SV) (221.21 KB - PDF)

Rodyti

Multimedia

The PRAC held a public hearing on quinolone and fluoroquinolone antibiotics on 13 June 2018.

The hearing was broadcast live on 13 June from 13:00 - 18:00 (UK time).

The video recording is available.

Share this page